(Q36501927)

English

The histone deacetylase inhibitor ITF2357 decreases surface CXCR4 and CCR5 expression on CD4( ) T-cells and monocytes and is superior to valproic acid for latent HIV-1 expression in vitro

scientific article published on May 2010

In more languages
default for all languages
No label defined

No description defined

Statements

The histone deacetylase inhibitor ITF2357 decreases surface CXCR4 and CCR5 expression on CD4( ) T-cells and monocytes and is superior to valproic acid for latent HIV-1 expression in vitro (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit